MeCP2 Binding Cooperativity Inhibits DNA Modification-Specific Recognition

Sergei Khrapunov, Yisong Tao, Huiyong Cheng, Camille Padlan, Richard Harris, Aristea S. Galanopoulou, John M. Greally, Mark E. Girvin, Michael D. Brenowitz

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Methyl-CpG binding protein 2 (MeCP2) is a multifunctional protein that guides neuronal development through its binding to DNA, recognition of sites of methyl-CpG (mCpG) DNA modification, and interaction with other regulatory proteins. Our study explores the relationship between mCpG and hydroxymethyl-CpG (hmCpG) recognition mediated by its mCpG binding domain (MBD) and binding cooperativity mediated by its C-terminal polypeptide. Previous study of the isolated MBD of MeCP2 documented an unusual mechanism by which ion uptake is required for discrimination of mCpG and hmCpG from CpG. MeCP2 binding cooperativity suppresses discrimination of modified DNA and is highly sensitive to both the total ion concentration and the type of counterions. Higher than physiological total ion concentrations completely suppress MeCP2 binding cooperativity, indicating a dominant electrostatic component to the interaction. Substitution of SO4 2- for Cl- at physiological total ion concentrations also suppresses MeCP2 binding cooperativity, This effect is of particular note as the intracellular Cl- concentration changes during neuronal development. A related effect is that the protein-stabilizing solutes, TMAO and glutamate, reduce MeCP2 (but not isolated MBD) binding affinity by 2 orders of magnitude without affecting the apparent binding cooperativity. These observations suggest that polypeptide flexibility facilitates DNA binding by MeCP2. Consistent with this view, nuclear magnetic resonance (NMR) analyses show that ions have discrete effects on the structure of MeCP2, both MBD and the C-terminal domains. Notably, anion substitution results in changes in the NMR chemical shifts of residues, including some whose mutation causes the autism spectrum disorder Rett syndrome. Binding cooperativity makes MeCP2 an effective competitor with histone H1 for accessible DNA sites. The relationship between MeCP2 binding specificity and cooperativity is discussed in the context of chromatin binding, neuronal function, and neuronal development.

Original languageEnglish (US)
Pages (from-to)4275-4285
Number of pages11
JournalBiochemistry
Volume55
Issue number31
DOIs
StatePublished - Aug 9 2016

Fingerprint

Methyl-CpG-Binding Protein 2
Protein Binding
DNA
Ions
Substitution reactions
Magnetic Resonance Spectroscopy
Nuclear magnetic resonance
Rett Syndrome
Peptides
Proteins
Chemical shift
Static Electricity
Histones
Chromatin
Anions
Glutamic Acid
Electrostatics

ASJC Scopus subject areas

  • Biochemistry
  • Medicine(all)

Cite this

MeCP2 Binding Cooperativity Inhibits DNA Modification-Specific Recognition. / Khrapunov, Sergei; Tao, Yisong; Cheng, Huiyong; Padlan, Camille; Harris, Richard; Galanopoulou, Aristea S.; Greally, John M.; Girvin, Mark E.; Brenowitz, Michael D.

In: Biochemistry, Vol. 55, No. 31, 09.08.2016, p. 4275-4285.

Research output: Contribution to journalArticle

Khrapunov, Sergei ; Tao, Yisong ; Cheng, Huiyong ; Padlan, Camille ; Harris, Richard ; Galanopoulou, Aristea S. ; Greally, John M. ; Girvin, Mark E. ; Brenowitz, Michael D. / MeCP2 Binding Cooperativity Inhibits DNA Modification-Specific Recognition. In: Biochemistry. 2016 ; Vol. 55, No. 31. pp. 4275-4285.
@article{8ad722bae787498ea0a10440fa68bd57,
title = "MeCP2 Binding Cooperativity Inhibits DNA Modification-Specific Recognition",
abstract = "Methyl-CpG binding protein 2 (MeCP2) is a multifunctional protein that guides neuronal development through its binding to DNA, recognition of sites of methyl-CpG (mCpG) DNA modification, and interaction with other regulatory proteins. Our study explores the relationship between mCpG and hydroxymethyl-CpG (hmCpG) recognition mediated by its mCpG binding domain (MBD) and binding cooperativity mediated by its C-terminal polypeptide. Previous study of the isolated MBD of MeCP2 documented an unusual mechanism by which ion uptake is required for discrimination of mCpG and hmCpG from CpG. MeCP2 binding cooperativity suppresses discrimination of modified DNA and is highly sensitive to both the total ion concentration and the type of counterions. Higher than physiological total ion concentrations completely suppress MeCP2 binding cooperativity, indicating a dominant electrostatic component to the interaction. Substitution of SO4 2- for Cl- at physiological total ion concentrations also suppresses MeCP2 binding cooperativity, This effect is of particular note as the intracellular Cl- concentration changes during neuronal development. A related effect is that the protein-stabilizing solutes, TMAO and glutamate, reduce MeCP2 (but not isolated MBD) binding affinity by 2 orders of magnitude without affecting the apparent binding cooperativity. These observations suggest that polypeptide flexibility facilitates DNA binding by MeCP2. Consistent with this view, nuclear magnetic resonance (NMR) analyses show that ions have discrete effects on the structure of MeCP2, both MBD and the C-terminal domains. Notably, anion substitution results in changes in the NMR chemical shifts of residues, including some whose mutation causes the autism spectrum disorder Rett syndrome. Binding cooperativity makes MeCP2 an effective competitor with histone H1 for accessible DNA sites. The relationship between MeCP2 binding specificity and cooperativity is discussed in the context of chromatin binding, neuronal function, and neuronal development.",
author = "Sergei Khrapunov and Yisong Tao and Huiyong Cheng and Camille Padlan and Richard Harris and Galanopoulou, {Aristea S.} and Greally, {John M.} and Girvin, {Mark E.} and Brenowitz, {Michael D.}",
year = "2016",
month = "8",
day = "9",
doi = "10.1021/acs.biochem.6b00451",
language = "English (US)",
volume = "55",
pages = "4275--4285",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "31",

}

TY - JOUR

T1 - MeCP2 Binding Cooperativity Inhibits DNA Modification-Specific Recognition

AU - Khrapunov, Sergei

AU - Tao, Yisong

AU - Cheng, Huiyong

AU - Padlan, Camille

AU - Harris, Richard

AU - Galanopoulou, Aristea S.

AU - Greally, John M.

AU - Girvin, Mark E.

AU - Brenowitz, Michael D.

PY - 2016/8/9

Y1 - 2016/8/9

N2 - Methyl-CpG binding protein 2 (MeCP2) is a multifunctional protein that guides neuronal development through its binding to DNA, recognition of sites of methyl-CpG (mCpG) DNA modification, and interaction with other regulatory proteins. Our study explores the relationship between mCpG and hydroxymethyl-CpG (hmCpG) recognition mediated by its mCpG binding domain (MBD) and binding cooperativity mediated by its C-terminal polypeptide. Previous study of the isolated MBD of MeCP2 documented an unusual mechanism by which ion uptake is required for discrimination of mCpG and hmCpG from CpG. MeCP2 binding cooperativity suppresses discrimination of modified DNA and is highly sensitive to both the total ion concentration and the type of counterions. Higher than physiological total ion concentrations completely suppress MeCP2 binding cooperativity, indicating a dominant electrostatic component to the interaction. Substitution of SO4 2- for Cl- at physiological total ion concentrations also suppresses MeCP2 binding cooperativity, This effect is of particular note as the intracellular Cl- concentration changes during neuronal development. A related effect is that the protein-stabilizing solutes, TMAO and glutamate, reduce MeCP2 (but not isolated MBD) binding affinity by 2 orders of magnitude without affecting the apparent binding cooperativity. These observations suggest that polypeptide flexibility facilitates DNA binding by MeCP2. Consistent with this view, nuclear magnetic resonance (NMR) analyses show that ions have discrete effects on the structure of MeCP2, both MBD and the C-terminal domains. Notably, anion substitution results in changes in the NMR chemical shifts of residues, including some whose mutation causes the autism spectrum disorder Rett syndrome. Binding cooperativity makes MeCP2 an effective competitor with histone H1 for accessible DNA sites. The relationship between MeCP2 binding specificity and cooperativity is discussed in the context of chromatin binding, neuronal function, and neuronal development.

AB - Methyl-CpG binding protein 2 (MeCP2) is a multifunctional protein that guides neuronal development through its binding to DNA, recognition of sites of methyl-CpG (mCpG) DNA modification, and interaction with other regulatory proteins. Our study explores the relationship between mCpG and hydroxymethyl-CpG (hmCpG) recognition mediated by its mCpG binding domain (MBD) and binding cooperativity mediated by its C-terminal polypeptide. Previous study of the isolated MBD of MeCP2 documented an unusual mechanism by which ion uptake is required for discrimination of mCpG and hmCpG from CpG. MeCP2 binding cooperativity suppresses discrimination of modified DNA and is highly sensitive to both the total ion concentration and the type of counterions. Higher than physiological total ion concentrations completely suppress MeCP2 binding cooperativity, indicating a dominant electrostatic component to the interaction. Substitution of SO4 2- for Cl- at physiological total ion concentrations also suppresses MeCP2 binding cooperativity, This effect is of particular note as the intracellular Cl- concentration changes during neuronal development. A related effect is that the protein-stabilizing solutes, TMAO and glutamate, reduce MeCP2 (but not isolated MBD) binding affinity by 2 orders of magnitude without affecting the apparent binding cooperativity. These observations suggest that polypeptide flexibility facilitates DNA binding by MeCP2. Consistent with this view, nuclear magnetic resonance (NMR) analyses show that ions have discrete effects on the structure of MeCP2, both MBD and the C-terminal domains. Notably, anion substitution results in changes in the NMR chemical shifts of residues, including some whose mutation causes the autism spectrum disorder Rett syndrome. Binding cooperativity makes MeCP2 an effective competitor with histone H1 for accessible DNA sites. The relationship between MeCP2 binding specificity and cooperativity is discussed in the context of chromatin binding, neuronal function, and neuronal development.

UR - http://www.scopus.com/inward/record.url?scp=84981225464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981225464&partnerID=8YFLogxK

U2 - 10.1021/acs.biochem.6b00451

DO - 10.1021/acs.biochem.6b00451

M3 - Article

VL - 55

SP - 4275

EP - 4285

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 31

ER -